Von der Lein says EU has reached COVID vaccine target | Coronavirus pandemic news

With the delta coronavirus variant spreading throughout the European Union, EU President Ursula von der Lein urged member states to increase vaccination.

European Commission President Ursula von der Lein said that the EU has provided member states with sufficient doses of coronavirus vaccine to achieve the goal of providing at least 70% of EU adults with comprehensive vaccination.

Von der Lein said on Twitter on May 9 that the EU is expected to achieve its goal of vaccinating 70% of adults before the summer. He urged EU countries to increase vaccination and said that by Sunday, the EU will distribute the vaccination throughout the Union. 500 million doses of vaccine.

“The EU keeps its promise. This weekend, we have provided enough vaccines to member states, and this month at least 70% of EU adults can be fully vaccinated,” Von der Lein said in a video statement on Saturday.

“But COVID-19 has not been defeated. We are ready to provide more vaccines, including vaccines for new variants,” said Von der Lein, who was severely criticized in early 2021 for failing to ensure the company’s delivery of contract vaccines.

The EU Joint Vaccine Procurement Plan managed by the European Commission has delivered 330 million BioNTech-Pfizer vaccines, 100 million AstraZeneca, 50 million vaccines from Moderna, and 20 million Johnson & Johnson.

The EU’s long-term goal is to have enough vaccines to vaccinate all eligible people by the end of September.

In her latest statement, Von der Lein added that the EU is prepared to provide more doses, including vaccines for new variants.

Sonia Gallegos of Al Jazeera from London said that despite the successful launch of the vaccine in the European Union, people still express real concerns about the highly contagious delta variant of the coronavirus, which first appeared in India.

“There is a very contagious variant of Delta that may sweep the entire African continent, which is why they urge member states to really start and really promote their own vaccination programs,” Gallegos said.

EU is Initial criticism Some companies received some criticism for the delay in negotiating contracts with drug suppliers, and later the plan was hampered by insufficient delivery by some companies, particularly AstraZeneca based in the United Kingdom.

However, as the industry raced to increase the production of newly developed vaccines, purchases began to flow in.

The European Commission said last week that EU countries had ordered nearly 40 million additional doses of vaccines produced by Johnson & Johnson.

The European Commission has previously warned that it has cited estimates from the European Union’s Disease Prevention Agency that the highly contagious delta variant of the coronavirus is expected to dominate Europe this summer.

Source link